Cancer · Austria
Endometrial cancer
How is it diagnosed today? Your family doctor asks about your symptoms and may examine your tummy and vagina; you can ask for a female doctor or nurse. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.7 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Hysterectomy, then radiotherapy or chemo if needed. MedlinePlus
4 medicines are approved for this disease in Austria:
- Dostarlimab (Jemperli) – approved in 2021
- Durvalumab (Imfinzi) – approved in 2018
- Olaparib (Lynparza) – approved in 2014
- Pembrolizumab (Keytruda, Keytruda Qlex) – approved in 2015
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (3)
- Cisplatin (Cisplatine Teva, Cisplatine Viatris) – approved for it in France
- Hydroxyprogesterone caproate (Hydroxyprogesterone Caproate) – approved for it in the US
- Lenvatinib (Lenvima, Lenvatinib Sandoz, Lenvatinib-Teva) – approved for it in the US and Switzerland
Being tested in people
7 open trials in Austria, 341 worldwide. See the trials
- Anlotinib hydrochloride capsule + TQB2450 injection (Phase 3)
- anti-PD1 agent therapy - 1 year (Phase 3)
- anti-PD1 agent therapy - 2 years (Phase 3)
- Bevacizumab (Phase 3)
Only in the lab or in animals
Not counted yet for this disease.
No proof it works
Animal worm medicines (ivermectin, fenbendazole) for cancer: not approved, and not enough research in people to know if they help. American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
1 open trial in Austria with these filters
Navtemadlin as Maintenance Treatment for Endometrial Cancer After Chemotherapy
NCT05797831 · ClinicalTrials.gov
- Graz – University Hospital Graz, Department of Gynecology and Obstetrics
- Innsbruck – Medizinische Universität Innsbruck
- Vienna – Medizinische Universität Wien
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
Available abroad (63 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Tests ifinatamab deruxtecan in several types of recurrent or spreading solid tumors
NCT06330064 · ClinicalTrials.gov
Countries: Belgium, Germany, Spain and 15 more
- Charleroi, Belgium – Grand Hopital de Charleroi
- Leuven, Belgium – UZ Leuven
- Liège, Belgium – Centre Hospitalier Universitaire de Liège
Age 18 and over
Contact the trial teamTests ubamatamab alone or with cemiplimab in recurrent ovarian and uterine cancers
NCT03564340 · ClinicalTrials.gov
Countries: Belgium, Spain, France and 7 more
- Edegem, Belgium – Antwerp University Hospital
- Leuven, Belgium – UZ Leuven
- Badalona, Spain – Institut Catala d'Oncologia
Age 18 and over
Contact the trial teamTests BI 3820768 dose tolerability in advanced germ cell, endometrial, or ovarian cancer
NCT07306559 · ClinicalTrials.gov
Countries: Germany, Spain, France and 1 more
- Munich, Germany – LMU Klinikum Muenchen AöR
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
- Madrid, Spain – Clinica Universidad de Navarra
Age 18 and over
Contact the trial teamCompares Rina-S with standard treatment in endometrial cancer that has returned or spread
2024-519818-31-01 · EU Clinical Trials Register
Countries: Belgium, Germany, Denmark and 7 more
- Charleroi, Belgium – Grand Hopital de Charleroi
- Edegem, Belgium – Universitair Ziekenhuis Antwerpen
- Hasselt, Belgium – JESSA Ziekenhuis
Age 18 and over
Contact the trial teamPersonalized Peptide Vaccine for High-Risk or Recurrent Endometrial Cancer
NCT07316361 · ClinicalTrials.gov
Countries: Greece
- Thessaloniki, Greece – Biogenea Pharmaceuticals Ltd & Interbalkan Medical Center - International Oncology Center
No age limit given in the registry
Contact the trial teamTests valemetostat in adults with certain advanced solid tumors
2024-519788-16-00 · EU Clinical Trials Register
Countries: France
- Bordeaux, France – Institut Bergonie
- Lyon, France – Centre Leon Berard
- Paris, France – Institut Curie
Age 18 and over
Contact the trial teamStudies Links Between Gene Changes, Lifestyle and Endometrial Cancer Recurrence
NCT06680791 · ClinicalTrials.gov
Countries: Czechia
- Prague, Czechia – Faculty Hospital Kralovske Vinohrady
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamRobot-assisted keyhole surgery to remove the pelvic organs for advanced cancer
NCT05186493 · ClinicalTrials.gov
Countries: Norway
- Oslo, Norway – Oslo University Hospital The Radium Hospital
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStudies how well hormone treatment works in advanced womb cancer
NCT03621904 · ClinicalTrials.gov
Countries: Netherlands
- Nijmegen, Netherlands – Radboudumc
Ages 18 to 110
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests nesuparib with pembrolizumab as first treatment for endometrial cancer
NCT06502743 · ClinicalTrials.gov
Countries: South Korea
- Goyang-si, South Korea – National Cancer Center
- Seongnam-si, South Korea – Seoul National University Bundang Hospital
- Seoul, South Korea – The Catholic University of Korea, Seoul ST. Mary's Hospital
Age 19 and over
Contact the trial teamCesium-131 radioactive seeds for cervical or endometrial cancer that returned in the vagina
NCT07631572 · ClinicalTrials.gov
Countries: United States
- Lexington, United States – University of Kentucky/Markey Cancer Center
Age 18 and over
Contact the trial teamTests DT2216 with paclitaxel in ovarian cancer that returned after platinum treatment
NCT06964009 · ClinicalTrials.gov
Countries: United States
- Boston, United States – Beth Israel Deaconess Medical Center (BIDMC)
- Boston, United States – Dana-Farber Cancer Institute
- Boston, United States – Brigham and Women's Hospital
Age 18 and over
Contact the trial teamTesting Nivolumab With or Without Ipilimumab in Recurrent Endometrial Cancer
NCT05112601 · ClinicalTrials.gov
Countries: United States
- Albuquerque, United States – University of New Mexico Cancer Center
- Anaconda, United States – Community Hospital of Anaconda
- Ashland, United States – Northwest Wisconsin Cancer Center
Age 18 and over
Contact the trial teamTesting different amounts of M1774 and ZEN-3694 for recurring ovarian and endometrial cancer
NCT05950464 · ClinicalTrials.gov
Countries: United States
- Albuquerque, United States – University of New Mexico Cancer Center
- Augusta, United States – Augusta University Medical Center
- Chicago, United States – University of Chicago Comprehensive Cancer Center
Age 18 and over
Contact the trial teamTesting OPB-201 cell therapy for recurrent endometrial cancer and platinum-resistant ovarian cancer
NCT07664735 · ClinicalTrials.gov
Countries: United States
- Atlanta, United States – Emory Winship Cancer Institute
- Detroit, United States – Karmanos Cancer Institute
- Houston, United States – MD Anderson Cancer Center
Age 18 and over
Contact the trial teamMocertatug rezetecan plus immunotherapy as ongoing treatment for advanced or recurrent endometrial cancer
NCT07684599 · ClinicalTrials.gov
Countries: Canada, Japan, South Korea
- Montreal, Canada – hospital not given
- Toronto, Canada – hospital not given
- Fukuoka, Japan – hospital not given
Age 18 and over
Contact the trial teamTests CR-002 in adults with advanced solid tumors
NCT07909031 · ClinicalTrials.gov
Countries: United States
- Austin, United States – hospital not given
- Dallas, United States – hospital not given
- Fairfax, United States – hospital not given
Age 18 and over
Contact the trial teamPF-08634404 With Chemotherapy for Advanced or Recurrent Endometrial Cancer
NCT07578649 · ClinicalTrials.gov
Countries: Australia, China, Japan and 2 more
- Campbelltown, Australia – GenesisCare - Campbelltown
- Frankston, Australia – Bayside Health - Peninsula University Hospital
- Toowoomba, Australia – Toowoomba Hospital
Age 18 and over
Contact the trial teamHB0025 added to chemotherapy for advanced or returning endometrial cancer
NCT07902999 · ClinicalTrials.gov
Countries: China
- Guangzhou, China – Sun Yat-sen University Cancer Center
- Shenyang, China – The First Affiliated Hospital of China Medical University
Age 18 and over
Contact the trial teamSTRO-006 for advanced solid tumors that have returned or spread
NCT07807345 · ClinicalTrials.gov
Countries: United States
- Boston, United States – Massachusetts General Brigham
- Fairfax, United States – NEXT Oncology- Virginia
- Irving, United States – Next Oncology Dallas
Age 18 and over
Contact the trial teamTests subcutaneous dostarlimab with chemotherapy for advanced endometrial cancer
NCT07860450 · ClinicalTrials.gov
Age 18 and over
Contact the trial teamTests enfortumab vedotin in endometrial cancer that has returned after treatment
NCT07139977 · ClinicalTrials.gov
Countries: United States
- Milwaukee, United States – Froedtert Memorial Lutheran Hospital
Age 18 and over
Contact the trial teamAn online and remote group program to ease fear of cancer progression in women
NCT07741968 · ClinicalTrials.gov
Countries: United States
- Arcadia, United States – City of Hope at Arcadia
- Duarte, United States – City of Hope Medical Center
- Huntington Beach, United States – City of Hope at Seacliff
Age 18 and over
Contact the trial teamTesting Zanzalintinib With Paclitaxel for Returning Uterine Cancer
NCT06795009 · ClinicalTrials.gov
Countries: United States
- Albuquerque, United States – University of New Mexico
- Oklahoma City, United States – University of Oklahoma
- San Francisco, United States – University of California San Francisco
Age 18 and over
Contact the trial teamStudies blood tests and tumor profiles to predict endometrial cancer recurrence
NCT05049538 · ClinicalTrials.gov
Countries: United States
- Houston, United States – M D Anderson Cancer Center
Age 18 and over
Contact the trial teamTests a radioactive antibody treatment in people with advanced solid tumors
NCT07189871 · ClinicalTrials.gov
Countries: United States
- Dothan, United States – Dothan Hematology & Oncology
- Grand Rapids, United States – BAMF Health
- Houston, United States – MD Anderson Cancer Center
Age 18 and over
Contact the trial teamPembrolizumab and Lenvatinib for Recurrent Endometrial Cancer After Earlier Immunotherapy
NCT07594015 · ClinicalTrials.gov
Countries: United States
- Miami, United States – University of Miami
Age 18 and over
Contact the trial teamTests STRO-004, alone or with pembrolizumab, in adults with metastatic solid tumors
NCT07227168 · ClinicalTrials.gov
Countries: United States
- Austin, United States – NEXT Austin
- Boston, United States – Mass General Cancer Center
- Denver, United States – SCRI Denver
Age 18 and over
Contact the trial teamTests tegavivint in young people with solid tumors that returned or resisted treatment
NCT04851119 · ClinicalTrials.gov
Countries: United States
- Ann Arbor, United States – C S Mott Children's Hospital
- Atlanta, United States – Children's Healthcare of Atlanta - Arthur M Blank Hospital
- Aurora, United States – Children's Hospital Colorado
Ages 1 to 30
Contact the trial teamTests NRM-823 in adults with certain advanced solid tumors
NCT07182149 · ClinicalTrials.gov
Countries: United States
- Boston, United States – hospital not given
- Charleston, United States – hospital not given
- Dallas, United States – hospital not given
Age 18 and over
Contact the trial teamTests sacituzumab govitecan with cisplatin for returning ovarian and uterine cancer
NCT06040970 · ClinicalTrials.gov
Countries: United States
- New York, United States – Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology
Age 18 and over
Contact the trial teamTUB-040 for Uterine Cancer That Returned or Worsened After Chemotherapy and Immune Therapy
NCT07743541 · ClinicalTrials.gov
Countries: United States
- East Brunswick, United States – START - New Jersey
- Lake Success, United States – START New York Long Island
- Los Angeles, United States – START - Los Angeles
Age 18 and over
Contact the trial teamCombined drug and radiation treatment for recurrent endometrial cancer
NCT05603910 · ClinicalTrials.gov
Countries: United States
- Miami, United States – University of Miami
Age 18 and over
Contact the trial teamElemene Liposomes with Chemotherapy in Advanced or Recurrent Endometrial Cancer
NCT07738315 · ClinicalTrials.gov
Countries: China
- Hangzhou, China – Women's hospital school of medicine Zhejiang University
Ages 18 to 80
Contact the trial teamTests abemaciclib in people with ovarian or endometrial cancer that has returned
NCT04469764 · ClinicalTrials.gov
Countries: United States
- Los Angeles, United States – UCLA / Jonsson Comprehensive Cancer Center
No age limit given in the registry
Contact the trial teamTesting avutometinib, defactinib and everolimus together for recurrent endometrial cancer with RAS changes
NCT07318324 · ClinicalTrials.gov
Countries: United States
- Houston, United States – MD Anderson Cancer Center
Age 18 and over
Contact the trial teamSafety of dostarlimab with chemotherapy for advanced or returned endometrial cancer in India
NCT07652515 · ClinicalTrials.gov
Age 18 and over
Contact the trial teamElacestrant plus everolimus for estrogen-sensitive endometrial cancer that has returned or spread
NCT07634601 · ClinicalTrials.gov
Countries: United States
- Los Angeles, United States – UCLA / Jonsson Comprehensive Cancer Center
Age 18 and over
Contact the trial teamUrine hormone tests in people with heavy or irregular periods to study uterine cancer
NCT07581288 · ClinicalTrials.gov
Countries: Canada
- Vancouver, Canada – Vancouver General Hospital Research Pavillion
Age 35 and over
Contact the trial teamCadonilimab with chemoradiation for returning or spreading endometrial cancer
NCT06532539 · ClinicalTrials.gov
Countries: China
- Jinan, China – Shandong Cancer Hospital Affiliated to Shandong First Medical University
Ages 18 to 80
Contact the trial team
Showing 40 of 63. Use the filters to narrow the list.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- Targeted next-generation sequencing-based mutational signature analysis in endometrial cancer: utility and limitations across molecular subtypes.J Pathol Transl Med · 2026-11-10
- ReviewGATA2: A Custodian of Endometrial Identity: Guarding the Uterine Lining in Health and Disease.Bioessays · 2026-11-01
- N6-methyladenosine reader IGF2BP3 promotes endometrial cancer progression via modification of circ-EPB41L2 expression.Oncol Lett · 2026-11-03
- In peopleEndometrial cancer outcomes among women with disabilities: treatment access and survival disparities using nationwide Korean data.BMC Health Serv Res · 2026-08-21
- ReviewMenstrual Disorders: Postmenopausal Uterine Bleeding.FP Essent · 2026-11-01
Is it true?
Saw something on social media? Fact-check it now.
Get screened
For family members and people at higher risk: free checks can find some cancers early, before there are symptoms.
There is no routine screening for this cancer. If you have symptoms or a family history, talk to your doctor.
If several people in your family had cancer, ask your GP whether genetic counselling makes sense for you.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Österreichische Krebshilfe
Free, anonymous counselling at regional centres in every federal state, psycho-oncology and emergency financial aid.
Phone: 01 7966450
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (5)
- ENGAGe - European Network of Gynaecological Cancer Advocacy Groups (ESGO)
ESGO network of 80+ gynaecological cancer patient groups; member list with country filter.
- European Cancer Patient Coalition (ECPC)
Umbrella of European cancer patient groups, with a patient toolbox and a legal network for cancer patients.
- International Gynecologic Cancer Advocacy Network
Advocacy network of the International Gynecologic Cancer Society: annual advocacy summit, education, advocacy directory; free patient education for survivors and carers
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.